Saliva could hold the key to diagnosing liver fibrosis
Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University and Gallipoli...
Search all articles from Emma O'Connor
Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University and Gallipoli...
Griffith University has named four winners at its prestigious Outstanding Alumni Awards 2024 ceremony in Brisbane with Leona Murphy taking out the top gong.
Malnutrition continues to be a widespread issue in Australian aged care homes, but Griffith University researchers are striving to address...
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.
Griffith University’s partnership with PsiQuantum will see a new ‘Test and Validation’ lab opened at Griffith’s Nathan campus. PsiQuantum will...
The mystery surrounding the targeted removal of red blood cells from the human body is at the centre of new Griffith University research.
A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
Griffith has been awarded nearly $3 million from the NHMRC 2023 Partnership Projects PRC2 round.
Professor Paul Clarke will join the University as the inaugural Executive Director of the new Institute for Biomedicine and Glycomics.
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic discovery capability under the leadership of Therapeutic Innovation Australia (TIA).